The American Association for Cancer Research (AACR) is accredited by the Accreditation Council of Continuing Medical Education (ACCME) to provide continuing medical education (CME) activities for physicians.
CREDIT DESIGNATION STATEMENT
The AACR has designated this live activity for a maximum of 45.5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
STATEMENT OF EDUCATIONAL NEED, TARGET AUDIENCE AND LEARNING OBJECTIVES
Advances in biomedical research continue to create significant opportunities for improving the detection, treatment and prevention of cancer. These advances include new technologies, scientific advances and exponential developments in the field of translational cancer medicine that have led to rapid changes in oncology. By bridging the gap between what physicians understand about cancer biology and the clinical applications, this meeting aids basic researchers, physicians and clinician-scientists in obtaining, synthesizing and integrating the most cutting-edge research into their practice. Further, facilitating the interface between physicians and scientists will increase knowledge of the epidemiological implications of cancer incidence and the contributions of laboratory research to drug development as well as patient care; transform the design and conduct of clinical research protocols; and create a forum for the rapid translation of laboratory research findings from “bench-to-bedside” for the benefit of improving patient outcomes.
After participating in this CME activity, participants will be able to:
- Identify the importance of technological advances and their use in accelerating research progress;
- Assimilate information from the basic and translational sciences to drug development, clinical research and new findings;
- Acquire knowledge on the use of molecular imaging and tumor profiling to more accurately develop treatment strategies;
- Formulate new strategies to improve patient selection (or stratification) for clinical trials through the use of biomarkers and other indicators;
- Apply the presented information and research to expedite development of detection, prevention and treatment strategies to reduce cancer incidence and mortality; and
- Develop collaborations amongst physicians, researchers and clinician-scientists to advance the cause of treating and preventing cancer.
It is the policy of the AACR that the information presented at CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, the AACR has provided information that Program Committee members, speakers and abstract presenters have disclosed about financial relationships they have with commercial entities that produce or market products or services related to the content of this CME activity. As part of AACR's policy on full disclosure of relevant financial relationships, the disclosure information will be available in the Annual Meeting Program/Proceedings and on this webpage as the meeting approaches.
ACKNOWLEDGMENT OF FINANCIAL OR OTHER SUPPORT
This activity is supported by professional educational grants and will be disclosed at the meeting.
QUESTIONS ABOUT CME?
Please contact the AACR Office of CME at (215) 440-9300 or email@example.com.